Jennison Associates

Jennison Associates Portfolio holdings

AUM $169B
1-Year Return 33.48%
 

Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.

This Quarter Return
+6.96%
1 Year Return
+33.48%
3 Year Return
+206.37%
5 Year Return
+330.72%
10 Year Return
+1,268.64%
AUM
$109B
AUM Growth
+$2.13B
Cap. Flow
-$3.08B
Cap. Flow %
-2.83%
Top 10 Hldgs %
21.04%
Holding
790
New
79
Increased
296
Reduced
318
Closed
88

Sector Composition

1 Healthcare 20.05%
2 Consumer Discretionary 14.71%
3 Technology 13%
4 Communication Services 12.47%
5 Financials 8.59%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
FEIC
476
DELISTED
FEI COMPANY
FEIC
$13.1M 0.01%
171,307
-3,004
-2% -$229K
CENX icon
477
Century Aluminum
CENX
$2.09B
$12.9M 0.01%
+932,585
New +$12.9M
AVDL
478
Avadel Pharmaceuticals
AVDL
$1.54B
$12.8M 0.01%
713,770
+2,263
+0.3% +$40.7K
MDGL icon
479
Madrigal Pharmaceuticals
MDGL
$9.59B
$12.7M 0.01%
186,776
+85,924
+85% +$5.83M
QLYS icon
480
Qualys
QLYS
$4.75B
$12.5M 0.01%
268,992
+16,900
+7% +$786K
FCSC
481
DELISTED
Fibrocell Science Inc.
FCSC
$11.9M 0.01%
175,848
-2,798
-2% -$189K
XNCR icon
482
Xencor
XNCR
$596M
$11.5M 0.01%
+750,508
New +$11.5M
CDW icon
483
CDW
CDW
$22.4B
$11M 0.01%
+294,668
New +$11M
RLYP
484
DELISTED
RELYPSA INC COM
RLYP
$10.8M 0.01%
+300,202
New +$10.8M
WBC
485
DELISTED
WABCO HOLDINGS INC.
WBC
$10.5M 0.01%
85,687
-17,848
-17% -$2.19M
FOMX
486
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$10.1M 0.01%
1,088,495
+480,847
+79% +$4.45M
LMOS
487
DELISTED
Lumos Networks Corp
LMOS
$10.1M 0.01%
658,660
-12,942
-2% -$197K
NXTM
488
DELISTED
NxStage Medical Inc.
NXTM
$9.98M 0.01%
+576,672
New +$9.98M
DSCI
489
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$9.63M 0.01%
1,136,928
+262
+0% +$2.22K
SPY icon
490
SPDR S&P 500 ETF Trust
SPY
$664B
$9.2M 0.01%
44,585
+41,903
+1,562% +$8.65M
BCRX icon
491
BioCryst Pharmaceuticals
BCRX
$1.68B
$8.79M 0.01%
+973,099
New +$8.79M
ACGN
492
DELISTED
Aceragen, Inc. Common Stock
ACGN
$7.95M 0.01%
+15,762
New +$7.95M
GNMX
493
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
$7.8M 0.01%
968,792
-12,400
-1% -$99.8K
DERM
494
DELISTED
Dermira, Inc.
DERM
$7.79M 0.01%
507,703
-16,275
-3% -$250K
ACT.PRA
495
DELISTED
ACTAVIS PLC PFD CONV SER A (IRL)
ACT.PRA
$7.59M 0.01%
+7,500
New +$7.59M
CNCE
496
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$7.27M 0.01%
+480,222
New +$7.27M
PSXP
497
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$7.15M 0.01%
101,200
-17,534
-15% -$1.24M
NVRO
498
DELISTED
NEVRO CORP.
NVRO
$6.95M 0.01%
144,946
-1,929
-1% -$92.5K
RGLS
499
DELISTED
Regulus Therapeutics
RGLS
$6.83M 0.01%
3,361
+10
+0.3% +$20.3K
TEP
500
DELISTED
Tallgrass Energy Partners, LP
TEP
$6.7M 0.01%
132,482
+11,981
+10% +$606K